← FDA Drug Approvals (Drugs@FDA)

EFAVIRENZ

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MICRO LABS LTD · Approved 2012-01-19

Drug application

FDA Application #

ANDA202042

Application type

Abbreviated New Drug Application (Generic)

Brand name

EFAVIRENZ

Generic name

Efavirenz

Active ingredients

EFAVIRENZ

Dosage form

CAPSULE

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

MICRO LABS LTD

First approval

2012-01-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown